Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Nasopharyngeal carcinoma; Epstein-Barr virus; Immunotherapy; Cellular-based therapy; Vaccination; Head and neck cancer; DC; dendritic cell; NK; natural killer cell; CTL; cytotoxic T lymphocyte/cell; NPC; nasopharyngeal carcinoma; HLA; human leukocyte anti
مقالات ISI آنتی بادی-وابسته به سمیت سلولی سلولی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Lectins; Molecular farming; Monoclonal antibodies; Plant secondary metabolites; Therapeutic anti-cancer vaccines; APIs; active pharmaceutical ingredients; ADCC; antibody-dependent cellular cytotoxicity; ADCs; antibody-drug conjugates; ATPS; aqueous two-
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; CDC; complement-dependent cytotoxicity; MAC; membrane attack complex; mCRP; membrane-bound complement regulatory protein; siRNA; small interfering RNA; ADCC; antibody-dependent cellular cytotoxicity; CDCC; complement-dependent cellular cytotoxicity; RTX;
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Natural killer cell modulation; Innate immunity; Cancer; Viral infection; Flavonoid; Isoflavones; ADCC; antibody-dependent cellular cytotoxicity; BCECF; 20-70-bis(carboxyethyl)-5(6)-carboxyfluorescein; BW; body weight; Ca2+; calcium; CD; cluster of diff
Comparability study of Rituximab originator and follow-on biopharmaceutical
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; AA; amino acid; ABC; ammonium bicarbonate; ACN; acetonitrile; ADCC; antibody-dependent cellular cytotoxicity; CD; circular dichroism; CDC; complement-dependent cytotoxicity; CDRs; complementarity determining regions; CH; constant region of heavy chain; CH
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; clearance; clinical pharmacokinetics; preclinical pharmacokinetics; proteins; simulations; AC; antigen concentration; ADCC; antibody-dependent cellular cytotoxicity; BrW; brain weight; CL; clearance; mAb; monoclonal antibody; MLP; maximum life span potent
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; A1AT; alpha-1-antitrypsin; ADCC; antibody-dependent cellular cytotoxicity; AEM; adenovirus expression medium; CHO; Chinese hamster ovary; sDHB; super-dihydroxybenzoic acid; Fc; fragment crystallizable; GalNAc; N-acetylgalactosamine; GlcNAc; N-acetylglucos
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; BM; bone marrow; CMV; cytomegalovirus; CRISPR; clustered regularly-interspaced short palindromic repeat; crRNA; CRISPR RNA; DTH; delayed-type hypersensitivity; HSCT; haematopoietic stem cell transplantation;
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; Ag; antigen; APC; antigen-presenting cell; DC; dendritic cells; K9-ACV; autologous canine cancer vaccine; LAL; limulus amebocyte lysate; NSCLC; non-small cell lung cancer; ODN; oligodeoxynucleotide; PAGE; po
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; CDC; complement-dependent cytotoxicity; cDNA; complementary DNA; CEL-seq; single-cell RNA-sequencing; DOC; doxorubicin; EMA; European Medicines Agency; ER; estrogen receptor; FRα; folate receptor alpha; HER
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; 2D-LC; two-dimensional liquid chromatography; AA; amino acid; AC; affinity chromatography; ADC; antibody-drug conjugates; ADCC; antibody-dependent cellular cytotoxicity; AF4; asymmetric flow field fractionation; APTS; 1-aminopyrene-3,6,8-trisulfonate; Asn
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; RA; rheumatoid arthritis; IFX; infliximab; ETN; etanercept; ADCC; antibody-dependent cellular cytotoxicity; CDC; complement-dependent cytotoxicity; CCP; cyclic citrullinated peptide; RF; rheumatoid factor; MMP-3; matrix-metalloproteinase-3; DAS28-ESR; dis
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; CDC; complement-dependent cytolysis; CDR; complementarity determining region; Fab; fragment antigen binding; H; antibody heavy chain; L; antibody light chain; Le; Lewis glycan epitope; PDB; protein data bank
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; AID; autoimmune disease; AIDS; acquired immunodeficiency syndrome; AMA-1; apical membrane antigen-1; APC; antigen presenting cell; ATG; anti-thymocyte globuline; BCG; Bacille Calmette-Guérin; BPRC; Biomedic
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADA; Anti-drug antibody(ies); ADCC; Antibody-dependent cellular cytotoxicity; AE; Adverse event; CBA; Cell-based assay; CDC; Complement dependent cytotoxicity; CLB; Competitive ligand binding; EIP; European Immunogenicity Platform; EIP-AWG; European Immun
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Claudin; Tight junction; Antibody therapy; Microenvironment; MIUC; muscle invasive urothelial cancers; CLDN; claudin; SPR; surface plasmon resonance; CDDP; cisplatinum; EGFR; epidermal growth factor receptor; ERK; extracellular signal-regulated kinase; EG
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Immunocytokines; Antibody-cytokine fusion proteins; Targeted cancer immunotherapy; ADCC; antibody-dependent cellular cytotoxicity; AICD; activation-induced cell death; APC; antigen presenting cell; CDC; complement-dependent cytotoxicity; CEA; carcinoemb
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; AQP4; aquaporin-4; BSA; bovine serum albumin; CDC; complement-dependent cytotoxicity; CNS; central nervous system; dSTORM; direct stochastic reconstruction microscopy; EDSS; expanded disability status scale;
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Epidermal growth factor receptor; Tyrosine kinase; Antibody-dependent cellular cytotoxicity; Targeted therapy;
Effects of amino acid substitutions on the biological activity of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Monoclonal antibody; Transgenic silkworm; Amino acid substitution; N-glycosylation; Fc-mediated effector function; ADCC; antibody-dependent cellular cytotoxicity; ADCP; antibody-dependent cellular phagocytosis; CBB; Coomassie Brilliant Blue; CDC; compleme
Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Head and neck cancer; Recurrent/metastatic; Anti-EGFR; Second line treatment; Progression-free survival; Gene expression signatures; Hypoxia signature; Microenvironment score; miRNA; EGFR; epidermal growth factor receptor; mAb; monoclonal antibody; RM; re
Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Anti-PD-L1; TGFβ; Immunogenic modulation; CTL-mediated lysis; Antibody-dependent cellular cytotoxicity; Bladder cancer;
Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Signal transducer and activator of transcription 1, gain of function; natural killer cell deficiency; perforin; Janus kinase inhibition; ruxolitinib; natural killer cell maturation; ADCC; Antibody-dependent cellular cytotoxicity; CCD; Coiled-coil domain;
Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; IBD; Glycans; Glycopeptides; Biomarker; A2; diantennary; A2B; structures with bisecting β(1,4) N-acetylglucosamine; A2F; fucosylated structures; ADCC; antibody-dependent cellular cytotoxicity; anti-TNF; inhibitor of tumor necrosis factor; AUC; area unde
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; Antibody-dependent cellular cytotoxicity; FoxP3; Regulatory T cell; T-cell receptor; Tumor immune microenvironment;
Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; AQP4; NMO; Fc multimer; Astrocyte; Complement; Immunoglobulin; Neuroinflammation; ADCC; antibody-dependent cellular cytotoxicity; AQP4; aquaporin-4; AQP4-IgG; neuromyelitis optica immunoglobulin G antibody; BSA; bovine serum albumin; CDC; complement-depen
The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; αβ; alpha beta; ADCC; antibody-dependent cellular cytotoxicity; APC; antigen-presenting cell; BrHPP; bromohydrin pyrophosphate; BTLA; B and T lymphocyte attenuator; CAR; chimeric antigen receptor; DC; dendritic cell; γc; common gamma; γδ; gamma delta
HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Gold nanoparticle; Trastuzumab resistance; HER2; Gastric cancer; Autophagy; Tmab; trastuzumab; HER2; human epidermal growth factor receptor 2; AuNP; gold nanoparticle; ECD; extracellular domain; ADCC; antibody-dependent cellular cytotoxicity; PTEN; phosph
A mathematical model of antibody-dependent cellular cytotoxicity (ADCC)
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Immunotherapy; Antibody-dependent cellular cytotoxicity; Ordinary differential equations; Asymptotic analysis;
New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura)
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; AECA; Anti-epithelial cell antibodies; ANCA; Anti-neutrophil cytoplasmic antibodies; β2GPI; β2-glycoprotein I; CDC; Complement-dependent cytotoxicity; EC; endothelial cell; FcαRI; Fc receptor for IgA; Gal
Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Influenza; Antibody-dependent cellular cytotoxicity; NK cell degranulation;
Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Ab; Antibodies; ADCC; Antibody-dependent cellular cytotoxicity; Ag; Antigen; BLAST; Basic local alignment search tool; BSA; Bovine serum albumin; CDC; Complement-dependent cytotoxicity; CDRs; Complementarity determining regions; CHO; Chinese hamster ovary
Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Crohn's Disease; Fcγ Receptor; Drug Modification; Mouse Model; ADA; adalimumab; ADAâÎF; hypo-fucosylated ADA; ADCC; antibody-dependent cellular cytotoxicity; FcγR; Fcγ-receptors; IBD; inflammatory bowel disease; IFNγ; interferon γ; Ig; immunoglo
SNPs rs4656317 and rs12071048 located within an enhancer in FCGR3A are in strong linkage disequilibrium with rs396991 and influence NK cell-mediated ADCC by transcriptional regulation
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Natural killer cells; FcγRIIIa; Antibody-dependent cellular cytotoxicity; Single nucleotide polymorphism; Linkage disequilibrium mapping;
Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Peptide; Antibody-dependent cellular cytotoxicity; Cytotoxic T lymphocytes; TAL6; TM4SF1; IFA; incomplete Freund's adjuvant; PELC; poly(ethylene glycol)-block-poly(lactideco-e-caprolactone) with squalene and Span®85; TAL6; tumor-associated antigen L6; TM
M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; Aichi; influenza A/Aichi/2/1968; APC; allophycocyanin; BAL; bronchoalveolar lavage; BSA; bovine serum albumin; CPE; cytopathic effect; FCS; fetal calf serum; FITC; fluorescein isothiocyanate; HAI; hemaggluti
An FDA oncology analysis of immune activating products and first-in-human dose selection
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; MABEL; Immune oncology; First-in-human dose; ADCC; antibody-dependent cellular cytotoxicity; CRA; cytokine release assay; CRS; cytokine release syndrome; DLT; dose limiting toxicity; EMA; European Medicines Agency; FIH; first-in-human; HHD; highest human
Immunoreceptors on neutrophils
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; ANCAs; anti-neutrophil autoantibodies; Btk; Bruton's tyrosine kinase; DAG; diacyl-glycerol; DAP12; DNAX activation protein of 12Â kDa; ERK; extracellular signal-regulated kinase; fMLP; N-Formylmethionine-leu
Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Cathepsin S; Fsn0503h antibody; Cathepsin S blockade; Cell invasiveness; Colo-205 xenografts; ADCC; antibody-dependent cellular cytotoxicity; ANOVA; analysis of variance; Cat-S; cathepsin S; DMSO; dimethyl sulfoxide; ECM; extracellular matrix; Emax; maxim
An FDA oncology analysis of antibody-drug conjugates
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; AD; acceptable dose; ADC; antibody-drug conjugate; ADCC; antibody-dependent cellular cytotoxicity; FIH; first-in-human; HNSTD; highest non-severely toxic dose; ICH; International Conference on Harmonization; LC/MS; liquid chromatography/mass spectrometry;
Associate editor: B. TeicherCD70: An emerging target in cancer immunotherapy
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; CD70; CD27; Cancer immunotherapy; Combination therapy; ADCC; Antibody-dependent cellular cytotoxicity; ADCP; Antibody-dependent cellular phagocytosis; CDC; Complement-dependent cellular cytotoxicity; CTLA-4; Cytotoxic T lymphocyte antigen-4; FOXP3; Forkhe
ReviewAlternative molecular formats and therapeutic applications for bispecific antibodies
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; ADCP; antibody-dependent cellular phagocytosis; ALL; acute lymphoblastic leukemia; AMD; age-related macular degeneration; AML; acute myeloid leukemia; BsAb; bispecific antibody; BsIgG; bispecific IgG; CDC; c
Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; E/T ratio; effector-to-target ratio; FcγR; Fcγ receptor; mAb; monoclonal antibody; MHC; major histocompatibility complex; NCR; natural cytotoxicity receptor; NK cell; natural killer cell; PBMCs; peripheral
Antibody-dependent cellular cytotoxicity and cytokine/chemokine secretion by KHYG-1 cells stably expressing FcγRIIIA
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; mAb; monoclonal antibody; ADCC; antibody-dependent cellular cytotoxicity; RTX; rituximab; TRA; trastuzumab; NK cell; natural killer cell; PBMC; peripheral blood mononuclear cell; NK cells; KHYG-1 cells; CD16A; FcγRIIIA; ADCC;
Comparison of the glycosylation of in vitro generated polyclonal human IgG and therapeutic immunoglobulins
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; FBS; fetal bovine serum; F; deoxyhexose (fucose); Gal; galactose; GlcNAc; N-acetylglucosamine; H; hexose, Hex; IVIG; intravenous immunoglobulin; LC; liquid chromatography; LTQ; linear trap quadrupole; MS; ma
Progress in HIV-1 vaccine development
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; HIV-1; vaccine; T cells; B cells; broadly neutralizing antibodies; ADCC; Antibody-dependent cellular cytotoxicity; BCR; B-cell antigen receptor; bnAb; Broad neutralizing antibody; Env; Envelope; gp; Glycoprotein; HC; Heavy chain; HCDR3; Immunoglobulin thi
AFM analysis of the multiple types of molecular interactions involved in rituximab lymphoma therapy on patient tumor cells and NK cells
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; Atomic force microscopy; Antibody-dependent cellular cytotoxicity; Lymphoma; Natural killer cell; CD20; Fc receptor;
Antilymphocyte autoantibodies generate T cell-C4d signatures in systemic lupus erythematosus
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; ALA; antilymphocyte autoantibodies; CB-CAPs; cell-bound complement activation products; C4d; complement C4 activation product C4d; Ig; immunoglobulin; T-C4d; TÂ cell-bound C4d; SLE; systemic lupus erythema
HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; HIV vaccine; HIV CD4i epitope; Rhesus macaque model; Replication-competent Ad; Systemic and mucosal adaptive immunity; Memory B and T cells; Antibody-dependent cellular cytotoxicity; Neutralizing antibody;
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations
Keywords: آنتی بادی-وابسته به سمیت سلولی سلولی; ADCC; antibody-dependent cellular cytotoxicity; ADCP; antibody-dependent cellular phagocytosis; BSA; bovine serum albumin; CDC; complement dependent cytotoxicity; D-PBS; Dulbecco's phosphate-buffered saline; ECD; extracellular domain; FACS; fluorescence